85% of Clinical Drug Trials Face Delays. What’s the True Cost?


Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays due to patient enrollment. Understanding that challenge and finding ways to minimize it is the pursuit of Jeeva Informatics. The company’s founder and CEO, Dr. Harsha Rajasimha, joined Kevin Stevenson on I Don’t Care to discuss the issue.

Dr. Rajasimha has a long history of clinical research experience, working as a data scientist and software engineer. After several personal tragedies, he wanted to apply his knowledge to helping clinical research trials overcome logistical burdens to bring new treatments to market faster.

“The biggest barrier in clinical trials is delays in the timeline associated with patient recruitment. Traditionally, those enrollees must be within 50 miles of the lab,” Dr. Rajasimha explained. That narrows down access considerably. “Only 1.2% of cancer patients in the U.S. are in a clinical trial.”

The other challenge is the logistics. Patients must travel to sites for treatment or simply just exchanges with physicians. “It’s a travel burden for patients and their caregivers,” Dr. Rajasimha noted.

To change the clinical trial ecosystem, Dr. Rajasimha said that the paradigm of the four walls of the lab must evolve. “Clinical trials have been slow to adopt digital channels, but the pandemic forced this.”

By digitizing and automating repetitive manual tasks, the burden of participation shrinks for the patient. “The pandemic showed that there is a demand for flexibility in decentralizing clinical trials. With the right tools, this is possible,” Dr. Rajasimha explained.

By leveraging technology, clinical trial producers can maximize diversity, equity, and inclusion. With more communication and interaction, patients in trials are also more likely to adhere to medication instructions and be more trusting of the process

More Like This Story:

Is the FDA’s Accelerated Approval of Molnupiravir Setting a Pharmaceutical Standard?

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!



Introducing Machine to Machine (M2M) Marketing: The Next Frontier in Business Automation
April 24, 2024

As the landscape of business and technology continues to evolve, a novel concept is emerging that may soon redefine the traditional marketing framework: Machine to Machine (M2M) Marketing. This innovative approach could fundamentally transform how businesses interact, making it crucial to explore its implications and potential.   The Rise of M2M Marketing M2M Marketing builds […]

Read More
personalized shopping in the future of retail
Trending Soon: Solving Customers’ Needs and Creating Personalized Shopping Experiences is the Future of Retail
April 24, 2024

One way that brands can enhance customer loyalty and increase their sales is by leveraging the growing consumer desire for easy and personalized shopping experiences.  In a recent segment of Experts Talk for a roundtable discussion on the present and future state of retail stores, Sarah Jarvis, a Retail Marketing and Loyalty Expert at […]

Read More
small retailers
Small Retailers are at the Forefront of Economic and Community Revival
April 24, 2024

As big-box retailers like Walmart and Target continue to expand their physical storefronts, small business retailers are carving out a niche by integrating deeply with their local communities. These local shops, unlike their gigantic counterparts, are leveraging their brick-and-mortar presence to enhance community ties and foster local economies. While large retailers invest in blending […]

Read More
When Using & Safeguarding Mass Amounts of Captured Data From Facility Monitoring Devices and Environments, Make it Meaningful
April 24, 2024

One of the many topics of ISC West 2024 was how the industry could overcome the strategic challenge of managing and safeguarding the massive amounts of data collected from facility monitoring devices. Cathal Walsh, the Vice President and Chief Security Officer at Guidepost Solutions, engages deeply with this issue and offered insights on refining […]

Read More